These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36281721)

  • 1. Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant
    Pallotto C; Tordi S; Pantanella R; Rosignoli D; Francisci D
    J Chemother; 2023 Sep; 35(5):465-469. PubMed ID: 36281721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with dalbavancin for long-term antimicrobial suppression of left ventricular assist device infections.
    Mansoor AE; Krekel T; Cabrera NL
    Transpl Infect Dis; 2023 Aug; 25(4):e14068. PubMed ID: 37159539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of a chronic wound and driveline infection after redo-LVAD implantation.
    Walter V; Stock UA; Soriano-Romero M; Schnitzbauer A; Moritz A; Beiras-Fernandez A
    J Cardiothorac Surg; 2014 Mar; 9():63. PubMed ID: 24685284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.
    Siegenthaler MP; Martin J; Pernice K; Doenst T; Sorg S; Trummer G; Friesewinkel O; Beyersdorf F
    Eur J Cardiothorac Surg; 2003 May; 23(5):748-54; discussion 754-5. PubMed ID: 12754028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: A single-center descriptive experience.
    Radcliffe C; Doilicho N; Niu YS; Grant M
    Transpl Infect Dis; 2020 Oct; 22(5):e13379. PubMed ID: 32574417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature.
    Levy DT; Steed ME; Rybak MJ; Guo Y; Gialanella P; Hanau L; Muggia V; Ostrowsky B
    Transpl Infect Dis; 2012 Oct; 14(5):E89-96. PubMed ID: 22931050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over 870 days of successful antibiotic suppression therapy for VRE-infected left ventricular assist device.
    Radcliffe C; Grant M
    J Card Surg; 2020 Jul; 35(7):1746-1748. PubMed ID: 32557822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
    Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
    Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
    Jennings DL; Chopra A; Chambers R; Morgan JA
    Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Treatment for Driveline Infection Following Implantation of a Ventricular Assist Device.
    Sezai A; Unosawa S; Taoka M; Osaka S; Kitazumi Y; Suzuki K; Nakai T; Tanaka M
    Heart Surg Forum; 2020 Mar; 23(2):E132-E134. PubMed ID: 32364899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorbable antibiotic beads for treatment of LVAD driveline infections.
    Wadiwala I; Garg P; Alamouti-Fard E; Landolfo K; Sareyyupoglu B; Ahmed ME; Jacob S; Pham S
    Artif Organs; 2024 May; 48(5):559-566. PubMed ID: 38400624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy and Outcome of Staphylococcus aureus Infections of Intracorporeal Ventricular Assist Devices.
    Ekkelenkamp MB; Vervoorn MT; Bayjanov JR; Fluit AC; Benaissa-Trouw BJ; Ramjankhan FZ
    Artif Organs; 2018 Oct; 42(10):983-991. PubMed ID: 29675919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series.
    Cikirikcioglu M; Ponchant K; Murith N; Meyer P; Yilmaz N; Huber C
    Int J Artif Organs; 2021 Nov; 44(11):912-916. PubMed ID: 34558333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device-related methicillin-susceptible Staphylococcus aureus bacteremia.
    Wilsey HA; Pisani B; O'Neill TJ
    J Card Surg; 2022 Jul; 37(7):2127-2130. PubMed ID: 35393639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections.
    Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G
    Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorbable antibiotic beads as an adjuvant therapy in treating ventricular assist devices driveline infection: A case report.
    Haddad O; Pham AN; Thomas M; Ali M; Sareyyupoglu B; El-Sayed Ahmed MM; Pham SM
    J Card Surg; 2020 Aug; 35(8):2073-2076. PubMed ID: 32652630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device-related infections: a multicentric study.
    Siméon S; Flécher E; Revest M; Niculescu M; Roussel JC; Michel M; Leprince P; Tattevin P
    Clin Microbiol Infect; 2017 Oct; 23(10):748-751. PubMed ID: 28323195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis.
    Juraszek A; Smólski M; Kołsut P; Szymański J; Litwiński P; Kuśmierski K; Zakrzewska-Koperska J; Sterliński M; Dziodzio T; Kuśmierczyk M
    J Cardiothorac Surg; 2021 Aug; 16(1):216. PubMed ID: 34344400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular assist device driveline infection: treatment with platelet-rich plasma.
    Jiritano F; Serraino GF; Rossi M; Dominijanni A; Brescia A; Renzulli A
    Ann Thorac Surg; 2013 Aug; 96(2):e37-8. PubMed ID: 23910142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Weekly Dalbavancin Dosing for the Treatment of Native Vertebral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus Aureus: A Case Report.
    Almangour TA; Fletcher V; Alessa M; Alhifany AA; Tabb D
    Am J Case Rep; 2017 Dec; 18():1315-1319. PubMed ID: 29222405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.